Name of Journal

The name of our journal is “The Nerve” since 2015 when it was first found. It is the official journal of The Korean Society of Peripheral Nervous System (www.kpns.or.kr)

Website

Official URL of Journal website
https://www.thenerve.net
eISSN
2465-891X
Aim & Scope
The Nerve publishes important issues covering all aspects of the peripheral and central nervous systems. Laboratorial investigations, original research articles, studies on valuable cases, technical notes of special surgical tactics or editorials in the field of neurosurgery, neurology and neuroscience are acceptable. All submitted manuscripts are peer-reviewed and review articles can only be published upon specific request of the editorial board.
Authorship
The Nerve follows the International Committee of Medical Journal Editors (ICMJE) criteria of authorship. All persons designated as authors should qualify for authorship, and will be required to submit a statement confirming that they meet the authorship criteria. The order of authorship should be a joint decision by all the co-authors. Every author should have participated sufficiently in the work to take public responsibility for the content.
Authorship credit should be based on authors fulfilling four criteria:
1. substantial contribution to conception and design, execution, or analysis and interpretation of data;
2. drafting the article or revising it critically;
3. reading and approval of the final version;
4. agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved
Acquisition of funding, collection of data, or general supervision of the research group alone does not, in themselves, constitute authorship. All non-authors who have made substantial contributions (including writing and editing assistance) must be named in the Acknowledgements and must have given permission to be named. Changes to the authorship list are not allowed after a paper has been accepted.

Members of the Data and Safety Monitoring Board (DSMB) (or Data Monitoring Committee [DMC]) should be independent of the trial and not be involved in the preparation of the manuscript for publication or act as an author on the paper.

For studies involving a large multicenter group, the group should jointly make a decision about authorship by listing only those members who qualify for authorship and are willing to accept responsibility for the manuscript as authors. List the other members of the group who have contributed to the study in the Acknowledgements section including their name and town. The National Library of Medicine (NLM) indexes the group name and authors and lists the names of collaborators if listed in Acknowledgements.

The involvement of a group in the authorship list should be indicated by the connector and with the name of the group, and all authors must be aware and agree to the submission of the paper to the Journal.

When the study has been carried out on behalf of a group, the connector for should be used in the authorship list. Contributors from the collaborating group(s) or investigators in the study can be listed in the appendix. When the authorship list contains a group name but no individual names, all members of the group must qualify for authorship and the members of the group listed in the acknowledgement section (including their name and town).

It is not recommended to submit an article that is conducted in collaboration with people with personal connections if not absolutely necessary. As stated we strictly follow the conduct of ICMJE for authorship. Authors need to take extra care if the person or people with personal connections is under 19 years of age. Before submission authors must contact the editor in chief via e-mail for the disclosure form for Involving People with Personal Connections. If the subject of the study seems not fit for the involved persons, the editor in-chief will reject the study that is to be submitted. Researchers should try to prevent any appearance of research misconduct when involving people with personal connections in research or publishing papers with them at all times.
Readership
The journal is primarily for professional physicians and researchers who are involved in the field of neuroscience, especially the peripheral nervous system (PNS). Due to the small number of journals regarding the field of PNS and its diseases, “The Nerve” aims to present high-quality studies in order to bring change in the medical world. Its readership can be expanded to other professions related in the heath field such as nurses and paramedics for recent updates with treatment and researches. Medical students and the public (especially families of patients) will have easy access to valuable information regarding peripheral and neurologic diseases. Policy makers will also be able to reflect the results of the articles to the nation-wide health care policies regarding the field of neuroscience and PNS.

Peer-review process

All studies that are submitted to The Nerve will be peer-reviewed in a double blinded system. The Editor will choose at least two anonymous reviewers for a fair and just evaluation. The corresponding author will be contacted as soon as possible if the study is rejected, accepted or needs revisions. It will take approximately one to two months, depending how much time is needed for revision, before the final decision of acceptance of publication.

When manuscripts are returned for revision, a cover letter from the Editor provides directions that should be followed carefully. Reviewers will either attach files or leave specific comments regarding revision of the study. Both authors and reviewers will have a deadline and they should contact the editorial office if the deadline cannot be met. Authors should include a response Letter, which describes how the manuscript has been revised and a detailed response to the Editor should be included with the revised manuscript.

If a manuscript is completely acceptable, according to the criteria set forth in these instructions, it is scheduled for publication in the next available issue. We neither guarantee the acceptance without review nor very short peer review times for unsolicited manuscripts. Commissioned manuscripts also are reviewed before publication.

Ownership and Management

The journal is owned by the publisher, Korean Society of Peripheral Nervous System
Contact information
St. Vincent Hospital Neurosurgery department
93, Jungbu-daero, Paldal-gu, Suwon-si, Gyeonggi-do, Republic of Korea,
TEL:+82-31-249-7196 Fax: +82-31-245-5208
Email: hyewon83v@naver.com
Management team
- Editor in chief
   Young-Jin Kim (Dankook University Hospital)
- Associate Editor
   Man Kyu Choi, (Kyung Hee University Hospital)
- Manuscript Editor
   Eun Ae Jung (Soonchuhyang University)
- Secretary of Publication
   Jin Shup So (Dankook University Hospital)
- Website and JATS XML File Producers
   Yoon-Sang Cho (M2PI, Korea)

Governing Body

The governing body of The Nerve is the editorial board
- https://www.thenerve.net/about/editorial.php

Contact information

Editorial office
Department of Neurosurgery, Dankook University Hospital
201, Manghyang-ro, Dongnam-gu, Cheonan-si, Chungcheongnam-do 31116,
South Korea
TEL: +82-41-550-6280, Fax: +82-41-556-0524
E-mail: spine1225@naver.com, mousehunt7@naver.com

Copyright and Licensing

Copyright policy
Korean Society of Peripheral Nervous System will become the owner of all published work at “The Nerve”. Copyright transfer agreement form should be signed when a study is submitted. Permission must be obtained from Korean Society of Peripheral Nervous System for any commercial use of materials.
Licensing information
This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose.
(http://creativecommons.org/licenses/by-nc/4.0/).
Deposit policy
Authors cannot archive preprint (i.e. prerefereeing), but they can archive postprint (i.e., final draft post-refereeing). Also, authors can archive publisher's version/PDF. The Nerve follows the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk/).

Publication Ethics

Before submitting any form of study, The Nerve, expects all authors to fully understand our ethics policies and be aware of the consequences if the terms are not met. There are growing concerns regarding increasing number of ethical issues in the academic field. Thus, strict guidelines are listed below in order to prevent any form of ethical misconduct. Also, The Nerve routinely screens submitted articles for plagiarism via professional anti-plagiarism companies (i.e. www.copykiller.com). Nevertheless, the guideline proposed in this journal is for prevention not for persecution. Authors must be aware of the ethical policies since incidences of copyright issues, plagiarism, redundant publication is usually due to lack of understanding rather than fraudulent intent.

The Nerve is in accordance with the strict ethics guidelines recommend by the Council of Science Editors (http://www.councilscienceeditors.org), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org), World Association of Medical Editors (WAME, http://www.wame.org), and the Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/en/main_en). Also, The Nerve, will follow the guidelines by the Committee on Publication Ethics (COPE) for settlement of any misconduct. If ethical misconduct is in fact found, the editorial board of The Nerve will not take it lightly. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and request apologies. Also, there can be possible sanctions, notification to other editors of other biomedical journals, and depending on the severity of the allegation, notify the author's institution

Please read carefully of the ethics code of the Nerve
https://www.thenerve.net/authors/ethics.php

Publication Schedule

The nerve publishes accepted studies twice a year (30^th April, 31^st October).

Publication fees

Starting from January 2023, all authors will be charged a submission fee of 100,000 KRW. The authors will have to wire transfer this amount to the bank account below. If receipts are necessary please contact the editorial office and the necessary document will be sent via mail.

Wire transfer bank account:
1002-963-899952, Woori Bank, Young Jin Kim
SWIFT CODE: HVBKKRSEXXX

“The Nerve” has regulations for publication fee waivers. Publication fees can be waivered if the author is from a developing country or from low-income economy or if the author can prove that he/she is under demonstrable needs. Please send an e-mail to the editor for the possibility of a waiver. After a thorough evaluation via a consultation with the editorial board the final decision will be made. Results will be sent by mail before the 1^st review.

Open access

This is an open access article distributed under the terms of the Creative Commons.

Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Archiving

The Journal is accessible at Korea Citation Index (https://www.kci.go.kr), or Science Central (www.e-sciencecentral.org) in the event a journal is no longer published.

Advertisement Regulations

We accept advertising and sponsorship for our journal’s main website under strict conditions mentioned below.

1) Advertisments and sponsorship is not related in anyway of the contents of the journal accepted to The Nerve.
2) Information regarding pre-published work or editorial contents are never provided to our Advertisers
3) Contents submitted to The Nerve is never altered to accommodate advertising.
4) Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
5) The Nerve will not hesitate to decline or cancel any advertisement at any time if ethical issues arise.
6) Advertisements for pharmaceutical products must confirm all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.